BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $909,000 | -26.4% | 19,085 | -40.2% | 0.87% | -35.0% |
Q2 2022 | $1,235,000 | -37.2% | 31,893 | -7.0% | 1.34% | -1.5% |
Q1 2022 | $1,965,000 | -48.8% | 34,296 | -28.7% | 1.37% | -25.8% |
Q4 2021 | $3,836,000 | -0.7% | 48,133 | +8.4% | 1.84% | +7.5% |
Q3 2021 | $3,862,000 | -31.9% | 44,390 | +0.8% | 1.71% | -34.4% |
Q2 2021 | $5,667,000 | +81.7% | 44,032 | +13.0% | 2.61% | +41.8% |
Q1 2021 | $3,119,000 | +34.4% | 38,966 | +37.1% | 1.84% | +4.3% |
Q4 2020 | $2,320,000 | – | 28,413 | – | 1.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |